Findings

What do systematic reviews say?

9 questions · 9 findings · 2 reviews

No studies found 2 · 22.2%GRADE not reported 0 · 0%Very low 1 · 11.1%Low 2 · 22.2%Moderate 4 · 44.4%High 0 · 0%

Endoscopic improvement (dichotomous) · Adult patients with active ulcerative colitis

Budesonide 10 mg showed no clear difference in endoscopic improvement compared with prednisolone 40 mg (low certainty).

1 finding from 1 review

Oral budesonide for induction of remission in ulcerative colitis 2015 · Cochrane Headline outcomes only
RR 0.94 [0.66, 1.33]
1 study · 72 participants
Low

Endoscopic improvement (dichotomous) · Adult patients with active ulcerative colitis

Budesonide probably leads to lower endoscopic improvement Gross 2011 compared with mesalamine (moderate certainty).

1 finding from 1 review

Oral budesonide for induction of remission in ulcerative colitis 2015 · Cochrane Headline outcomes only
RR 0.84 [0.74, 0.95]
1 study · 343 participants
Moderate

Endoscopic improvement (dichotomous) · Adult patients with active ulcerative colitis

Budesonide MMX® 6 mg showed no clear difference in endoscopic improvement compared with placebo (moderate certainty).

1 finding from 1 review

Oral budesonide for induction of remission in ulcerative colitis 2015 · Cochrane Headline outcomes only
RR 0.96 [0.73, 1.27]
2 studies · 440 participants
Moderate

Endoscopic improvement (dichotomous) · Adult patients with active ulcerative colitis

Budesonide MMX® 9 mg probably leads to higher endoscopic improvement compared with placebo (moderate certainty).

1 finding from 1 review

Oral budesonide for induction of remission in ulcerative colitis 2015 · Cochrane Headline outcomes only
RR 1.29 [1.01, 1.66]
2 studies · 442 participants
Moderate

Endoscopic improvement (dichotomous) · Adult patients with active ulcerative colitis

Budesonide MMX® 9 mg showed no clear difference in endoscopic improvement compared with entocort EC 9mg (moderate certainty).

1 finding from 1 review

Oral budesonide for induction of remission in ulcerative colitis 2015 · Cochrane Headline outcomes only
RR 1.14 [0.82, 1.6]
1 study · 212 participants
Moderate

Endoscopic improvement (continuous) · active EoE patients

The review found no eligible studies for this question.

1 finding from 1 review

Medical treatment of eosinophilic esophagitis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Endoscopic improvement (dichotomous) · active EoE patients

1 finding from 1 review

Medical treatment of eosinophilic esophagitis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 25 participants
Very low

Endoscopic improvement (continuous) · active EoE patients

1 finding from 1 review

Medical treatment of eosinophilic esophagitis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 111 participants
Low

Endoscopic improvement (dichotomous) · active EoE patients

The review found no eligible studies for this question.

1 finding from 1 review

Medical treatment of eosinophilic esophagitis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found